Bill

Bill > HB1337


HI HB1337

HI HB1337
Relating To Psilocybin.


summary

Introduced
01/25/2023
In Committee
01/30/2023
Crossed Over
Passed
Dead
05/03/2024

Introduced Session

2023 Regular Session

Bill Summary

Establishes the Therapeutic Psilocybin Working Group.

AI Summary

This bill establishes the Therapeutic Psilocybin Working Group within the Department of Health to examine the medicinal and therapeutic effects of psilocybin or psilocybin-based products in treating mental health conditions, including post-traumatic stress disorder, depression, anxiety, and end-of-life psychological distress. The working group will also examine the effectiveness of medicinal and therapeutic uses of psilocybin in states that have legalized it, such as Oregon and Colorado, and develop a long-term strategic plan to ensure the safe availability and accessibility of affordable, therapeutic psilocybin or psilocybin-based products for adults 21 years of age or older. The working group will submit a report of its findings and recommendations, including any proposed legislation, to the legislature prior to the convening of the 2024 regular session.

Committee Categories

Health and Social Services

Sponsors (10)

Last Action

Carried over to 2024 Regular Session. (on 12/11/2023)

Taxonomy

Health
  • ‐ Mental Illness, Mental Retardation, and Deinstitutionalization
  • ‐ Regulation of Drug Industry and Pharmacies

bill text


bill summary

Loading...

bill summary

Loading...
Loading...